210 related articles for article (PubMed ID: 9626929)
1. Monoclonal antibodies with specificities for Streptococcus pneumoniae group 9 capsular polysaccharides.
Kolberg J; Jones C
FEMS Immunol Med Microbiol; 1998 Apr; 20(4):249-55. PubMed ID: 9626929
[TBL] [Abstract][Full Text] [Related]
2. Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type-9V conjugate.
Lee CJ; Karpas A; Wang TR; Kosaka T; Koizumi K
Microbiol Immunol; 1996; 40(11):857-65. PubMed ID: 8985941
[TBL] [Abstract][Full Text] [Related]
3. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
Sun Y; Hwang Yi; Nahm MH
Infect Immun; 2001 Jan; 69(1):336-44. PubMed ID: 11119522
[TBL] [Abstract][Full Text] [Related]
4. Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers.
Szu SC; Lee CJ; Parke JC; Schiffman G; Henrichsen J; Austrian R; Rastogi SC; Robbins JB
Infect Immun; 1982 Mar; 35(3):777-82. PubMed ID: 7068216
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical characterization of cross-reactivity of pneumococcal group 9 capsular polysaccharide types 9N, 9A, 9L, and 9V.
Szu S; Lee CJ; Carlo D; Henrichsen J
Infect Immun; 1981 Jan; 31(1):371-9. PubMed ID: 7216451
[TBL] [Abstract][Full Text] [Related]
6. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate Specificity and Isotypes of Monoclonal and Polyclonal Antibodies to Conjugated Tetrasaccharide, a Synthetic Analogue of Repeating Unit of Capsular Polysaccharide of Streptococcus Pneumoniae Serotype 14.
Kurbatova ЕА; Yakovleva IV; Akhmatova EА; Sukhova ЕV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Bull Exp Biol Med; 2019 Feb; 166(4):477-480. PubMed ID: 30788740
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques.
McNeely TB; Staub JM; Rusk CM; Blum MJ; Donnelly JJ
Infect Immun; 1998 Aug; 66(8):3705-10. PubMed ID: 9673252
[TBL] [Abstract][Full Text] [Related]
9. Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.
Babb R; Doyle CR; Pirofski LA
Microbiol Spectr; 2021 Dec; 9(3):e0144621. PubMed ID: 34756090
[TBL] [Abstract][Full Text] [Related]
10. A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.
Ozdilek A; Huang J; Babb R; Paschall AV; Middleton DR; Duke JA; Pirofski LA; Mousa JJ; Avci FY
mBio; 2021 Jun; 12(3):e0080021. PubMed ID: 34061603
[TBL] [Abstract][Full Text] [Related]
11. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
[TBL] [Abstract][Full Text] [Related]
12. Murine monoclonal antibodies against pneumococcal capsular polysaccharide types 4, 8, 22F and 19A/19F.
Kolberg J; Aaberge IS; Jantzen E; Løvik M; Lermark G; Steen T
APMIS; 1992 Jan; 100(1):91-4. PubMed ID: 1311182
[TBL] [Abstract][Full Text] [Related]
13. Developing an ELISA using serotype-specific antigens from selected pneumococcal strains of own selection.
Slotved HC; Jacobsen JN; Møller HK; Krogfelt KA
Vaccine; 2007 Mar; 25(13):2513-7. PubMed ID: 17007972
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hurpin CM; Carosella ED; Cazenave PA
Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
[TBL] [Abstract][Full Text] [Related]
15. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci.
Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G
Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105
[TBL] [Abstract][Full Text] [Related]
16. Human antibody responses to pneumococcal surface protein A and capsular polysaccharides during acute and convalescent stages of invasive disease in adult patients.
Kolberg J; Aase A; Naess LM; Aaberge IS; Caugant DA
Pathog Dis; 2014 Feb; 70(1):40-50. PubMed ID: 24151210
[TBL] [Abstract][Full Text] [Related]
17. Production of monovalent antisera by induction of immunological tolerance for capsular typing of Streptococcus pneumoniae.
Henrichsen J; Robbins JB
FEMS Microbiol Lett; 1992 Jul; 73(1-2):89-93. PubMed ID: 1521777
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic studies of group 9 pneumococci in terms of protein type and 9N versus 9V capsular type.
Waltman WD; Gray BM; Svanborg C; Facklam R; Briles DE
J Infect Dis; 1991 Apr; 163(4):812-8. PubMed ID: 2010634
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody.
Sørensen UB; Agger R; Bennedsen J; Henrichsen J
Infect Immun; 1984 Mar; 43(3):876-8. PubMed ID: 6199306
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults.
Coughlin RT; White AC; Anderson CA; Carlone GM; Klein DL; Treanor J
Vaccine; 1998 Nov; 16(18):1761-7. PubMed ID: 9778753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
